Trial Profile
Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Radiant Research
- 14 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2008 New trial record.